Hemostatic management of patients undergoing ear-nose-throat surgery.

Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA (2001) 16.98

2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J (2014) 9.73

Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med (2013) 6.40

Aspirin in patients undergoing noncardiac surgery. N Engl J Med (2014) 6.10

Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.29

Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 4.30

Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. JAMA (2013) 4.27

Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation (1994) 3.65

Coronary artery stenting and non-cardiac surgery--a prospective outcome study. Br J Anaesth (2006) 3.08

Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. Circulation (2013) 3.02

A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa. Nat Med (2013) 2.84

A specific antidote for dabigatran: functional and structural characterization. Blood (2013) 2.77

The usefulness of preoperative laboratory screening. JAMA (1985) 2.55

Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends. Lancet (2009) 2.53

EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary. Eur Heart J (2013) 2.52

Peri-operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (ÖGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC). Thromb Haemost (2011) 1.85

Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. British Committee for Standards in Haematology. Br J Haematol (2008) 1.80

Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. Br J Anaesth (2010) 1.71

Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry. Blood (2014) 1.61

Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. Blood (2012) 1.59

Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF). Circulation (2014) 1.54

Cytochrome P450 3A inhibition by ketoconazole affects prasugrel and clopidogrel pharmacokinetics and pharmacodynamics differently. Clin Pharmacol Ther (2007) 1.45

Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. JAMA (2012) 1.43

Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans. J Clin Pharmacol (2009) 1.41

Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol (2001) 1.40

[Preoperative evaluation of the bleeding history. Recommendations of the working group on perioperative coagulation of the Austrian Society for Anaesthesia, Resuscitation and Intensive Care]. Anaesthesist (2007) 1.21

Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv (2013) 1.14

Risk of stroke after surgery in patients with and without chronic atrial fibrillation. J Thromb Haemost (2010) 1.13

Extracorporeal therapy for dabigatran removal in the treatment of acute bleeding: a single center experience. Clin J Am Soc Nephrol (2013) 1.11

Pharmacokinetics, pharmacodynamics, safety and tolerability of multiple ascending doses of ticagrelor in healthy volunteers. Br J Clin Pharmacol (2010) 1.06

Post-tonsillectomy hemorrhage: an assessment of risk factors. Int J Pediatr Otorhinolaryngol (1996) 0.99

Perioperative management of patients on chronic antithrombotic therapy. Blood (2012) 0.99

Perioperative management of patients who are receiving warfarin therapy: an evidence-based and practical approach. Blood (2011) 0.96

A practical concept for preoperative identification of patients with impaired primary hemostasis. Clin Appl Thromb Hemost (2004) 0.95

Determination of dabigatran, rivaroxaban and apixaban by ultra-performance liquid chromatography - tandem mass spectrometry (UPLC-MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants. J Thromb Haemost (2014) 0.95

Myocardial infarction after aspirin cessation in stable coronary artery disease patients. Int J Cardiol (2001) 0.92

Incidence of deep venous thrombosis and pulmonary embolism in otolaryngology-head and neck surgery. Otolaryngol Head Neck Surg (1998) 0.91

Platelet transfusion for reversal of dual antiplatelet therapy in patients requiring urgent surgery: a pilot study. J Thromb Haemost (2012) 0.88

The need for routine pre-operative coagulation screening tests (prothrombin time PT/partial thromboplastin time PTT) for healthy children undergoing elective tonsillectomy and/or adenoidectomy. Int J Pediatr Otorhinolaryngol (2001) 0.88

Reversal of the anti-platelet effects of aspirin and clopidogrel. J Thromb Haemost (2012) 0.87

[Risk of hemorrhage after adenoidectomy and tonsillectomy. Value of the preoperative determination of partial thromboplastin time, prothrombin time and platelet count]. HNO (2008) 0.84

[Significance of blood tests prior to adenoidectomy]. Laryngorhinootologie (2007) 0.83

Stratifying the risk of venous thromboembolism in otolaryngology. Otolaryngol Head Neck Surg (2012) 0.83

[Preoperative coagulation screening prior to adenoidectomy and tonsillectomy]. Klin Padiatr (2005) 0.82

A comparison of the antiplatelet effects of prasugrel and high-dose clopidogrel as assessed by VASP-phosphorylation and light transmission aggregometry. Thromb Haemost (2008) 0.82

Platelet function normalization after a prasugrel loading-dose: time-dependent effect of platelet supplementation. J Thromb Haemost (2013) 0.81

Everolimus-eluting stents in patients undergoing percutaneous coronary intervention: final 3-year results of the Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions trial. Am Heart J (2013) 0.80

Acquired hemophilia with inhibitors presenting as an emergency: misinterpretation of clotting results during direct oral anticoagulation. Dtsch Arztebl Int (2014) 0.79

Venous thromboembolism in patients with head and neck cancer after surgery. Head Neck (2012) 0.79

Bleeding complications in patients with coronary stents during non-cardiac surgery. Thromb Res (2014) 0.79

[ENT surgery in patients with anticoagulants and platelet aggregation inhibitors]. HNO (2014) 0.79

Risk of complications due to anticoagulation during dermatosurgical procedures: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol (2014) 0.78

Antiplatelet therapy in ENT surgery: a review. J Laryngol Otol (2011) 0.77

[Hemostatic management of patients undergoing ear-nose-throat-surgery]. Laryngorhinootologie (2015) 0.76

Incidence of venous thromboembolism in otolaryngology-head and neck surgery. JAMA Otolaryngol Head Neck Surg (2013) 0.76

Periprocedural antiplatelet therapy: recommendations for standardized reporting in patients on antiplatelet therapy: communication from the SSC of the ISTH. J Thromb Haemost (2013) 0.76

Antiplatelet drugs in elective ENT surgery. J Laryngol Otol (2012) 0.76

Prospective study of venous thromboembolism in patients with head and neck cancer after surgery. JAMA Otolaryngol Head Neck Surg (2013) 0.76

[Heparin-induced thrombocytopenia]. Internist (Berl) (2010) 0.76

The yin and yang of perioperative medicine. N Engl J Med (2014) 0.76

Analysis of the causes of immediate unanticipated bleeding after pediatric adenotonsillectomy. Int J Pediatr Otorhinolaryngol (2003) 0.76

Prospective study of venous thromboembolism in patients with head and neck cancer after surgery: interim analysis. JAMA Otolaryngol Head Neck Surg (2013) 0.76